Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cajuput oil is a volatile essential oil obtained by steam distillation from the leaves and twigs of myrtaceous trees such as Melaleuca leucadendra and Melaleuca cajuputi. It is primarily composed of cineole (also known as eucalyptol), which imparts its characteristic odor similar to eucalyptus and camphor. Cajuput oil is used in traditional medicine for topical pain relief (as a counterirritant), treatment of colds, congestion, headaches, toothache, skin infections, minor wounds and rashes. Its mechanism of action when applied topically involves causing surface warmth and irritation through cineole-mediated vasodilation and sensory nerve stimulation. It is also an ingredient in some liniments (e.g., Tiger Balm) for sore muscles and in inhalants or decongestants[2][4][5]. Cajeput oil may interact with drugs metabolized by cytochrome P450 2D6 enzymes[1][3]. The majority of global production occurs in Indonesia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cajuput oil.